Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Aug;35(33):e2211130.
doi: 10.1002/adma.202211130. Epub 2023 Jun 29.

Harnessing Nanomaterials for Cancer Sonodynamic Immunotherapy

Shuang Liang  1   2 , Jianjun Yao  1   2   3 , Dan Liu  1   2 , Lang Rao  4 , Xiaoyuan Chen  5   6   7   8 , Zhaohui Wang  1   2
Affiliations
Review

Harnessing Nanomaterials for Cancer Sonodynamic Immunotherapy

Shuang Liang et al. Adv Mater. 2023 Aug.

Abstract

Immunotherapy has made remarkable strides in cancer therapy over the past decade. However, such emerging therapy still suffers from the low response rates and immune-related adverse events. Various strategies have been developed to overcome these serious challenges. Therein, sonodynamic therapy (SDT), as a non-invasive treatment, has received ever-increasing attention especially in the treatment of deep-seated tumors. Significantly, SDT can effectively induce immunogenic cell death to trigger systemic anti-tumor immune response, termed sonodynamic immunotherapy. The rapid development of nanotechnology has revolutionized SDT effects with robust immune response induction. As a result, more and more innovative nanosonosensitizers and synergistic treatment modalities are established with superior efficacy and safe profile. In this review, the recent advances in cancer sonodynamic immunotherapy are summarized with a particular emphasis on how nanotechnology can be explored to harness SDT for amplifying anti-tumor immune response. Moreover, the current challenges in this field and the prospects for its clinical translation are also presented. It is anticipated that this review can provide rational guidance and facilitate the development of nanomaterials-assisted sonodynamic immunotherapy, helping to pave the way for next-generation cancer therapy and eventually achieve a durable response in patients.

Keywords: immunosuppressive tumor microenvironment; immunotherapy; nanomaterials; nanosonosensitizers; sonodynamic therapy.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. J. M. Banales, J. J. G. Marin, A. Lamarca, P. M. Rodrigues, S. A. Khan, L. R. Roberts, V. Cardinale, G. Carpino, J. B. Andersen, C. Braconi, D. F. Calvisi, M. J. Perugorria, L. Fabris, L. Boulter, R. I. R. Macias, E. Gaudio, D. Alvaro, S. A. Gradilone, M. Strazzabosco, M. Marzioni, C. Coulouarn, L. Fouassier, C. Raggi, P. Invernizzi, J. C. Mertens, A. Moncsek, S. Rizvi, J. Heimbach, B. G. Koerkamp, J. Bruix, et al., Nat. Rev. Gastroenterol. Hepatol. 2020, 17, 557.
    1. a) E. Frei, 3rd, Cancer 1982, 50, 1979;
    1. b) Y. Lee, S. L. Auh, Y. Wang, B. Burnette, Y. Wang, Y. Meng, M. Beckett, R. Sharma, R. Chin, T. Tu, R. R. Weichselbaum, Y. Fu, Blood 2009, 114, 589;
    1. c) G. Rosen, R. C. Marcove, B. Caparros, A. Nirenberg, C. Kosloff, A. G. Huvos, Cancer 1979, 43, 2163.
    1. A. Urruticoechea, R. Alemany, J. Balart, A. Villanueva, F. Vinals, G. Capella, Curr. Pharm. Des. 2010, 16, 3.

Substances

LinkOut - more resources

-